ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
0
views
0
references
Top references
cited by
8
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,550
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Safety and efficacy of TNFalpha blockade in relapsing vasculitis.
Author(s):
D Jayne
,
Clare P. Andrews
,
W Ayliffe
,
J Jefferson
,
Stephanie Booth
Publication date:
2002-05-31
Journal:
Annals of the Rheumatic Diseases
Keywords:
Adult
,
Aged
,
Antibodies, Monoclonal
,
administration & dosage
,
adverse effects
,
Antirheumatic Agents
,
Female
,
Granulomatosis with Polyangiitis
,
drug therapy
,
Humans
,
Infusions, Intravenous
,
Male
,
Middle Aged
,
Recurrence
,
Tumor Necrosis Factor-alpha
,
antagonists & inhibitors
,
Vasculitis
Read this article at
ScienceOpen
PMC
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Efficacy of Communicating Science
Author and article information
Journal
PubMed ID::
12006335
PMC ID::
1754125
ScienceOpen disciplines:
Chemistry
Keywords:
Adult
,
Aged
,
Antibodies, Monoclonal
,
administration & dosage
,
adverse effects
,
Antirheumatic Agents
,
Female
,
Granulomatosis with Polyangiitis
,
drug therapy
,
Humans
,
Infusions, Intravenous
,
Male
,
Middle Aged
,
Recurrence
,
Tumor Necrosis Factor-alpha
,
antagonists & inhibitors
,
Vasculitis
Data availability:
ScienceOpen disciplines:
Chemistry
Keywords:
Adult
,
Aged
,
Antibodies, Monoclonal
,
administration & dosage
,
adverse effects
,
Antirheumatic Agents
,
Female
,
Granulomatosis with Polyangiitis
,
drug therapy
,
Humans
,
Infusions, Intravenous
,
Male
,
Middle Aged
,
Recurrence
,
Tumor Necrosis Factor-alpha
,
antagonists & inhibitors
,
Vasculitis
Comments
Comment on this article
Sign in to comment
Similar content
2,550
Diagnosis and treatment of cutaneous leukocytoclastic vasculitis
Authors:
Carmen E Gota
,
Leonard Calabrese
Etiological and clinicopathological study of secondary small vessel vasculitis in elderly: A case series of 12 patients
Authors:
Ajay Kumar Mishra
,
Ramya Iyadurai
,
Anu George
…
Macular lymphocytic arteritis: Clinical-pathologic correlation of a rare vasculitis
Authors:
John G Zampella
,
Sharif Vakili
,
Stefan Doig
…
See all similar
Cited by
7
Biologics for the treatment of autoimmune renal diseases.
Authors:
Stephen Holdsworth
,
Poh-Yi Gan
,
A. Kitching
Wegener's granulomatosis: current and upcoming therapies
Authors:
Carol A. Langford
Prolonged Treatment with Low-Dose Intravenous Pulse Cyclophosphamide May Reduce Rate of Relapse in ANCA-Associated Vasculitis
Authors:
Ajay Dhaygude
,
Megan Griffith
,
Thomas Cairns
…
See all cited by